August 27, 2014 7:45 PM ET

Biotechnology

Company Overview of A-CUBE, Inc.

Company Overview

A-CUBE, Inc. engages in discovering druggable targets suitable for developing human therapeutic interventions. The company specializes in identifying B-cell epitopes, which are the binding sites for monoclonal antibodies and neutralizing antibodies. The company’s proprietary algorithm is applicable to proteins with 3D structure or amino acid sequence. Its technology is used in various applications, including generating new IP against clinically validated targets; validating mAbs in an existing development portfolio; designing new vaccines; predicting epitopes on proteins; and determining a modified and less immunogenic structure of chronically administered proteins that induce neutralizing a...

530 Harbor Boulevard

Belmont, CA 94002-4021

United States

Founded in 2003

Phone:

650-610-9100

Fax:

650-610-9110

Key Executives for A-CUBE, Inc.

Chief Executive Officer and Director
Age: 61
President
Executive Director
Vice President of Monoclonals
Bioinformation Scientist
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
ProImmune Inc. United States
Abbott Molecular Inc. United States
Genyous Life Sciences United States
MitoStem Inc. United States
Epeius Biotechnologies Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact A-CUBE, Inc., please visit www.acube.cc. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.